戴纳基公布24个月数据:Z-rostudirsen在DMD治疗中显著改善心肺功能

美股速递
Mar 09

最新公布的24个月临床数据显示,戴纳基(Dyne Therapeutics)研发的Z-rostudirsen在治疗杜氏肌营养不良症(DMD)过程中,对患者的心肺功能产生持续性改善。这一突破性进展为DMD患者提供了新的治疗希望。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10